265 related articles for article (PubMed ID: 18347183)
1. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors.
Gilg AG; Tye SL; Tolliver LB; Wheeler WG; Visconti RP; Duncan JD; Kostova FV; Bolds LN; Toole BP; Maria BL
Clin Cancer Res; 2008 Mar; 14(6):1804-13. PubMed ID: 18347183
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronan regulates ceruloplasmin production by gliomas and their treatment-resistant multipotent progenitors.
Tye SL; Gilg AG; Tolliver LB; Wheeler WG; Toole BP; Maria BL
J Child Neurol; 2008 Oct; 23(10):1221-30. PubMed ID: 18952589
[TBL] [Abstract][Full Text] [Related]
3. Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.
Yang T; Witham TF; Villa L; Erff M; Attanucci J; Watkins S; Kondziolka D; Okada H; Pollack IF; Chambers WH
Cancer Res; 2002 May; 62(9):2583-91. PubMed ID: 11980653
[TBL] [Abstract][Full Text] [Related]
4. Interferon-gamma inhibits proliferation and adhesion of T98G human malignant glioma cells in vitro.
Knüpfer MM; Poppenborg H; Van Gool S; Domula M; Wolff JE
Klin Padiatr; 1997; 209(4):271-4. PubMed ID: 9293461
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid inhibits proliferation and changes expression of CD44 and CD56 of malignant glioma cells in vitro.
Knüpfer MM; Hernáiz-Driever P; Poppenborg H; Wolff JE; Cinatl J
Anticancer Res; 1998; 18(5A):3585-9. PubMed ID: 9858943
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of folate-PAMAM for the delivery of antisense oligonucleotides to rat C6 glioma cells in vitro and in vivo.
Kang C; Yuan X; Li F; Pu P; Yu S; Shen C; Zhang Z; Zhang Y
J Biomed Mater Res A; 2010 May; 93(2):585-94. PubMed ID: 19591231
[TBL] [Abstract][Full Text] [Related]
7. [Effects of recombinant human bone morphogenic protein-2 and hyaluronic acid on invasion of brain glioma in vivo].
Zhang X; Wu J; Li X; Fu L; Gao D; Bai H; Liu X
Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):90-3. PubMed ID: 11953135
[TBL] [Abstract][Full Text] [Related]
8. Glioma invasion in vitro is mediated by CD44-hyaluronan interactions.
Radotra B; McCormick D
J Pathol; 1997 Apr; 181(4):434-8. PubMed ID: 9196442
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.
Lun XQ; Jang JH; Tang N; Deng H; Head R; Bell JC; Stojdl DF; Nutt CL; Senger DL; Forsyth PA; McCart JA
Clin Cancer Res; 2009 Apr; 15(8):2777-88. PubMed ID: 19351762
[TBL] [Abstract][Full Text] [Related]
10. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
[TBL] [Abstract][Full Text] [Related]
11. Interferon gamma inhibits proliferation and hyaluronic acid adhesion of human malignant glioma cells in vitro.
Knüpfer MM; Knüpfer H; Van Gool S; Domula M; Wolff JE
Cytokine; 2000 Apr; 12(4):409-12. PubMed ID: 10805225
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin-mediated enhanced hyaluronan binding induces multidrug resistance in mesothelioma cells.
Tajima K; Ohashi R; Sekido Y; Hida T; Nara T; Hashimoto M; Iwakami S; Minakata K; Yae T; Takahashi F; Saya H; Takahashi K
Oncogene; 2010 Apr; 29(13):1941-51. PubMed ID: 20101228
[TBL] [Abstract][Full Text] [Related]
13. Targeting hyaluronan interactions in spinal cord astrocytomas and diffuse pontine gliomas.
Maria BL; Gupta N; Gilg AG; Abdel-Wahab M; Leonard AP; Slomiany M; Wheeler WG; Tolliver LB; Babcock MA; Lucas JT; Toole BP
J Child Neurol; 2008 Oct; 23(10):1214-20. PubMed ID: 18952588
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid binding capacity of malignant glioma cells.
Knüpfer MM; Poppenborg H; Hotfilder M; Domula M; Wolff JE
Anticancer Res; 1998; 18(1A):353-6. PubMed ID: 9568102
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo.
Sun JY; Yang H; Miao S; Li JP; Wang SW; Zhu MZ; Xie YH; Wang JB; Liu Z; Yang Q
Phytomedicine; 2009 Nov; 16(11):1070-4. PubMed ID: 19427771
[TBL] [Abstract][Full Text] [Related]
16. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jan; 132(1):19-24. PubMed ID: 16415424
[TBL] [Abstract][Full Text] [Related]
17. [Connexin 43 gene in the in vivo treatment of cerebral glioma in C6 rats].
Xia Z; Pu P; Huang Q; Zhang Y; Jiang Y; You Y
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):212-4. PubMed ID: 12515608
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effect of 125IUdR on the glioma cell line C6 in vitro and in vivo].
Wu B; You C; Liu XD; Cai BW
Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):671-4. PubMed ID: 15460416
[TBL] [Abstract][Full Text] [Related]
19. BEHAB (brain enriched hyaluronan binding) is expressed in surgical samples of glioma and in intracranial grafts of invasive glioma cell lines.
Jaworski DM; Kelly GM; Piepmeier JM; Hockfield S
Cancer Res; 1996 May; 56(10):2293-8. PubMed ID: 8625302
[TBL] [Abstract][Full Text] [Related]
20. PKC-induced stiffening of hyaluronan/CD44 linkage; local force measurements on glioma cells.
Lamontagne CA; Grandbois M
Exp Cell Res; 2008 Jan; 314(2):227-36. PubMed ID: 17698062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
